The drug on Wednesday had also won priority review from the U.S. regulator for treating patients with untreated extensive-stage small cell lung cancer.
Roche’s lung cancer combo treatment wins FDA approval
More from Industry NewsMore posts in Industry News »
- Aurobindo, Unichem recall products in US market
- After recommending booster dose for 40+, INSACOG says more experiments needed
- Omicron scare: Experts advise booster doses for health workers
- BioNTech CEO confident of quickly adapting vaccine for Omicron
- Double vaccinate against Covid first, experts say amid calls for booster shots